GlobeNewswire Inc.··NaAllogene Therapeutics Raises $175M Via Stock Offering to Fund Clinical Pipeline
Allogene prices 87.5M shares at $2.00 each, raising $175M gross proceeds for clinical trials and R&D operations.
ALLOclinical trialspublic offering